Breakthrough Breast Cancer's Comment On New Targeted Antibody Therapy For Advanced Her2-Positive Breast Cancer
Main Category: Breast CancerAlso Included In: Cancer / Oncology; Women's Health / Gynecology
Article Date: 02 Jun 2009 - 4:00 PDT
| Patient / Public: | ![]() |
|
| Healthcare Prof: | ![]() |
3 (1 votes) |
Dr Alexis Willett, Head of Policy & Involvement at Breakthrough Breast Cancer, says:
"This study suggests that patients with HER2 positive advanced breast cancer who are no longer responding to Herceptin or chemotherapy may benefit from the combined Herceptin and DM1 treatment. Whilst many patients responded to the treatment in this trial, further larger studies will be needed to assess the full benefits.
"There are limited treatments available for those with advanced breast cancer so improving the range of options is always welcome and we look forward to the results of the ongoing trials of this treatment."
Source
Breakthrough Breast Cancer
Visit our breast cancer section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/152203.php>
APA
http://www.medicalnewstoday.com/releases/152203.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





